Acute Lymphoblastic Leukemia treatment protocol for children and adolescent
Phase 3
Recruiting
- Conditions
- Acute Lymphoblastic Leukemia of children and adolescent patientsC04.557.337.428.600
- Registration Number
- RBR-6pmfz8
- Lead Sponsor
- Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Will be eligible for this study all patients aged < 18 years (up to 17.99 years ) diagnosed with previously untreated ALL, with emphasis on no steroid use.
The requisites for proper leukemia diagnostic profile are: cytomorphological analysis, cytochemistry, immunephenotyping spinal fluid profile, cytogenetics and molecular biology
All patients and their legal representatives should be informed about the investigative nature of this study and must sign and provide free and informed consent in accordance with institutional and federal recommendations.
Exclusion Criteria
Without Informed Consent Term.
ALL patient aged > 18 years.
Prior use of corticosteroids.
Not confirmed the ALL diagnosis, after Central review.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method